How should jittery, choreiform movements caused by a basal ganglia hemorrhage be managed?

Management of Choreiform Movements from Basal Ganglia Hemorrhage

Risperidone is the treatment of choice for managing hemichorea-hemiballismus secondary to basal ganglia hemorrhage, with demonstrated effectiveness in achieving complete symptom resolution.

Primary Treatment Approach

The most recent high-quality evidence demonstrates that risperidone, an atypical antipsychotic, effectively controls violent involuntary choreiform movements caused by basal ganglia hemorrhage 1. This 2025 case report showed remarkable response in a patient with hemichorea-hemiballismus from subacute basal ganglia hemorrhage, providing a nonsurgical management option for this debilitating condition.

Alternative Pharmacological Option

For seizure-like choreiform movements specifically triggered by voluntary movement, carbamazepine can completely abolish symptoms 2. This is particularly relevant when the movements are:

• Induced only by voluntary movement
• Followed by transient paralysis
• Occurring without epileptiform discharges on EEG

Critical Differential Diagnosis

Before initiating antipsychotic therapy, you must rule out hyperglycemic chorea, which requires entirely different management:

Check Blood Glucose Immediately

• If glucose >300 mg/dL with HbA1c >9%, consider Chorea Hyperglycemia Basal Ganglia Syndrome (CHBG) 3, 4
• MRI will show characteristic T1 hyperintensity in basal ganglia contralateral to choreiform movements
• Gradual glycemic control over 48 hours leads to complete symptom resolution without need for antipsychotics 3, 4

Treatment Algorithm

1. Immediate assessment: Check blood glucose, obtain brain imaging if not already done
2. If hyperglycemic (>300 mg/dL): Implement gradual glycemic control; symptoms should resolve within 48 hours
3. If normoglycemic with confirmed hemorrhage: Initiate risperidone for hemichorea-hemiballismus
4. If movement-induced with seizure-like quality: Consider carbamazepine trial

Common Pitfalls

• Do not aggressively lower blood glucose in CHBG—gradual control over 48 hours prevents complications while allowing symptom resolution
• Do not assume all choreiform movements require antipsychotics—metabolic causes (hyperglycemia) are reversible with appropriate management
• The 2022 AHA/ASA ICH guidelines 5 focus on hemorrhage etiology workup but do not address movement disorder management, requiring clinician judgment based on case reports

Imaging Considerations

While the AHA/ASA guidelines 5 recommend vascular imaging workup for underlying causes of ICH, this is separate from acute movement disorder management. The movement disorder treatment should proceed concurrently with standard ICH workup protocols.